EPISODE · Jul 9, 2025 · 1H 1M
From Scientist to Startup Founder: Building the Virtual Cell for Drug Discovery | Natalie Ma, Deep Origin
from Startup and Nation · host Meng Fei Shen
In this episode of Startup & Nation, we dive deep with Natalie Ma, co-founder and head of business development at Deep Origin. Natalie's journey from environmental science undergraduate to co-founding a startup is a fascinating tale of curiosity-driven transitions. We explore her path through a PhD in synthetic biology, frustrations with the slow application of academic research, and a fortuitous meeting that led her to startups. Natalie explains how Deep Origin aims to build a 'virtual cell' to reduce failures in drug discovery and development, discusses market validation for biotech startups, and elaborates on the importance of industry-academic collaboration. This insightful conversation covers the challenges of translating academic research to practical applications, the nuances of market needs, and the role AI could play in regulatory processes. Tune in to understand the dynamic world of biotech innovation and the human-centric approaches driving it forward.00:00 Introduction to Natalie Ma and Deep Origin01:30 Natalie's Journey from Academia to Industry05:43 Challenges and Insights in Biotech Startups11:56 Deep Origin's Mission and Innovations19:33 Balancing Social Impact and Profit23:44 Cultural and Practical Differences Between Academia and Industry33:33 The Challenge of Valuing Research34:39 Practical Problem-Solving in Academia36:51 Bridging the Gap Between Academia and Industry37:32 Teaching Open-Ended Questioning40:35 The Role of AI in Research and Regulation50:14 How to think about Public-Private Partnerships53:35 Networking and Overcoming Social Anxiety59:22 Final Thoughts and Call to Action
What this episode covers
In this episode of Startup & Nation, we dive deep with Natalie Ma, co-founder and head of business development at Deep Origin. Natalie's journey from environmental science undergraduate to co-founding a startup is a fascinating tale of curiosity-driven transitions. We explore her path through a PhD in synthetic biology, frustrations with the slow application of academic research, and a fortuitous meeting that led her to startups. Natalie explains how Deep Origin aims to build a 'virtual cell' to reduce failures in drug discovery and development, discusses market validation for biotech startups, and elaborates on the importance of industry-academic collaboration. This insightful conversation covers the challenges of translating academic research to practical applications, the nuances of market needs, and the role AI could play in regulatory processes. Tune in to understand the dynamic world of biotech innovation and the human-centric approaches driving it forward.00:00 Introduction to Natalie Ma and Deep Origin01:30 Natalie's Journey from Academia to Industry05:43 Challenges and Insights in Biotech Startups11:56 Deep Origin's Mission and Innovations19:33 Balancing Social Impact and Profit23:44 Cultural and Practical Differences Between Academia and Industry33:33 The Challenge of Valuing Research34:39 Practical Problem-Solving in Academia36:51 Bridging the Gap Between Academia and Industry37:32 Teaching Open-Ended Questioning40:35 The Role of AI in Research and Regulation50:14 How to think about Public-Private Partnerships53:35 Networking and Overcoming Social Anxiety59:22 Final Thoughts and Call to Action
NOW PLAYING
From Scientist to Startup Founder: Building the Virtual Cell for Drug Discovery | Natalie Ma, Deep Origin
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.